1.Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 1. Introduction
Sung Woo PARK ; Ae Rin BAEK ; Hong Lyeol LEE ; Sung Whan JEONG ; Sei Hoon YANG ; Yong Hyun KIM ; Man Pyo CHUNG ;
Tuberculosis and Respiratory Diseases 2019;82(4):269-276
Idiopathic interstitial pneumonia (IIP) is a histologically identifiable pulmonary disease without a known cause that usually infiltrates the lung interstitium. IIP is largely classified into idiopathic pulmonary fibrosis, idiopathic non-specific interstitial pneumonia, respiratory bronchiolitis-interstitial lung disease (ILD), cryptogenic organizing pneumonia, desquamative interstitial pneumonia, and acute interstitial pneumonia. Each of these diseases has a different prognosis and requires specific treatment, and a multidisciplinary approach that combines chest high-resolution computed tomography (HRCT), histological findings, and clinical findings is necessary for their diagnosis. Diagnosis of IIP is made based on clinical presentation, chest HRCT findings, results of pulmonary function tests, and histological findings. For histological diagnosis, video-assisted thoracoscopic biopsy and transbronchial lung biopsy are used. In order to identify ILD associated with connective tissue disease, autoimmune antibody tests may also be necessary. Many biomarkers associated with disease prognosis have been recently discovered, and future research on their clinical significance is necessary. The diagnosis of ILD is difficult because patterns of ILD are both complicated and variable. Therefore, as with other diseases, accurate history taking and meticulous physical examination are crucial.
Biomarkers
;
Biopsy
;
Classification
;
Connective Tissue Diseases
;
Cryptogenic Organizing Pneumonia
;
Diagnosis
;
Idiopathic Interstitial Pneumonias
;
Idiopathic Pulmonary Fibrosis
;
Lung
;
Lung Diseases
;
Lung Diseases, Interstitial
;
Physical Examination
;
Prognosis
;
Respiratory Function Tests
;
Thorax
2.The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015.
Young Seok SEO ; Mi Sook KIM ; Jin Kyu KANG ; Won Il JANG ; Hee Jin KIM ; Chul Koo CHO ; Hyung Jun YOO ; Eun Kyung PAIK ; Yu Jin CHA ; Jae Sun YOON
Cancer Research and Treatment 2018;50(2):345-355
PURPOSE: The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2011 and 2015. MATERIALS AND METHODS: We analyzed the claims data from the Health Insurance Review and Assessment Service to estimate the clinical utilization of RT. The source population consisted of all patients who had any of the International Classification of Diseases 10th revision cancer diagnoses (C00-C97) and those with diagnostic codes D00-D48, who were also associated with at least one of the procedure codes related to RT. RESULTS: The total number of patients who received RT in 2011, 2012, 2013, 2014, and 2015 were 54,810, 59,435, 61,839, 64,062, and 66,183, respectively. Among them, the total numbers of male and female patients were 24,946/29,864 in 2011, 27,211/32,224 in 2012, 28,111/33,728 in 2013, 29,312/34,750 in 2014, and 30,266/35,917 in 2015. The utilization rate of RT in cancer patients has also increased steadily over the same period from 25% to 30%. The five cancers that were most frequently treated with RT between 2011 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. More than half of cancer patients (64%) were treated with RT in the capital area (Seoul, Gyeonggi, and Incheon). CONCLUSION: The total number of patients who underwent RT increased steadily from 2011 to 2015 in Korea. The utilization rate of RT in cancer patients is also increasing.
Breast
;
Diagnosis
;
Female
;
Gyeonggi-do
;
Humans
;
Insurance, Health
;
International Classification of Diseases
;
Korea*
;
Liver
;
Lung
;
Male
;
Prostatic Neoplasms
;
Radiotherapy
;
Uterine Cervical Neoplasms
3.The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea.
Boram PARK ; Soyoung YOUN ; Ki Kyung YI ; Su yeon LEE ; Jung Sun LEE ; Seockhoon CHUNG
Psychiatry Investigation 2017;14(5):618-625
OBJECTIVE: Among the various psychiatric disorders, depression is a common comorbid condition in cancer patients. Due to the distinct and diverse nature of cancer, the prevalence of depression may be assumed to be affected by differences in primary cancer sites. In this study, we explored the prevalence rates of depression among the ten most prevalent cancers in South Korea using a national patient sample. METHODS: This was a 1-year cross-sectional study using a national patient sample provided by the South Korean National Health Insurance in 2011. We selected all patients who had received ICD-10 codes of the 10 most prevalent cancers and major depressive disorder. Afterwards, the cancer and depression groups were merged and analyzed. RESULTS: The MDD prevalence rate was highest in lung cancer (11.0%), followed by non-Hodgkin's lymphoma (9.2%), prostate (9.1%), bladder (8.8%), breast (7.8%), cervix (7.8%), colorectal (7.7%), stomach (6.9%), liver (6.5%), and thyroid cancer (5.6%). Within all cancer groups, patients with a MDD diagnosis were significantly older (p<0.05) than non-MDD patients. Colorectal, stomach, and thyroid cancer displayed a higher female proportion in the MDD group than the non-MDD group. In the subgroup analysis, the prevalence rate differed by age and sex. CONCLUSION: The prevalence of depression varied according to cancer types. Patients with lung cancer were the most prone to experience depression. Because clinical and psychological factors may influence MDD prevalence, these factors will need to be studied more closely in the future.
Breast
;
Cervix Uteri
;
Cross-Sectional Studies
;
Depression*
;
Depressive Disorder, Major
;
Diagnosis
;
Epidemiology
;
Female
;
Humans
;
International Classification of Diseases
;
Korea*
;
Liver
;
Lung Neoplasms
;
Lymphoma, Non-Hodgkin
;
National Health Programs
;
Prevalence*
;
Prostate
;
Psychology
;
Stomach
;
Thyroid Neoplasms
;
Urinary Bladder
4.Tuberous sclerosis complex: Imaging characteristics in 11 cases and review of the literature.
Shan HU ; Dao-Yu HU ; Wen-Zhen ZHU ; Liang WANG ; Zi WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(4):601-606
Tuberous sclerosis complex (TSC) is an uncommon multiorgan disorder that may present many and different manifestations on imaging. Radiology plays an important role in diagnosis and management, and can substantially improve the clinical outcome of TSC. Therefore, a comprehensive understanding of this disease is essential for the radiologist. The manifestations of TSC on computer tomography (CT) and magnetic resonance (MR) images were analyzed. Eleven patients with a clinical diagnosis of TSC were retrospectively reviewed. Central nervous system lesions included subependymal nodules (SENs) (11/11), subependymal giant cell astrocytomas (SEGAs) (2/11), cortical and subcortical tuber lesions (5/11), and white matter lesions (4/11). Of the 6 patients with abdominal scans, there were 6 cases of renal angiomyolipomas (AMLs), and one case of hepatic AMLs. Of the 4 patients undergoing chest CT, lung lymhangioleiomyomatosis (LAM) (2/4), and multiple small sclerotic bone lesions (2/4) were observed. Different modalities show different sensitivity to the lesion. Analysis of images should be integrated with patients' history in order to diagnose TSC.
Adolescent
;
Adult
;
Brain
;
diagnostic imaging
;
pathology
;
Child
;
Child, Preschool
;
Female
;
Glioma, Subependymal
;
diagnosis
;
diagnostic imaging
;
pathology
;
Humans
;
Lung
;
diagnostic imaging
;
pathology
;
Magnetic Resonance Imaging
;
methods
;
Male
;
Middle Aged
;
Nervous System Diseases
;
diagnosis
;
diagnostic imaging
;
pathology
;
Tuberous Sclerosis
;
classification
;
diagnosis
;
diagnostic imaging
;
pathology
5.Atypical Wegener's Granulomatosis Accompanied with Rheumatoid Arthritis: A Case Report.
Laboratory Medicine Online 2015;5(3):161-164
Wegener's granulomatosis (WG) is highly correlated with cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA). Patients with rheumatoid arthritis (RA) rarely contract WG. Although several concurrent cases have been reported overseas, there are no known cases in Korea. Here we report a unique case of RA with atypical WG testing positive for perinuclear ANCA (p-ANCA) and negative for anti-myeloperoxidase (MPO) antibodies. The 62-yr-old female patient presented with multiple joint pain and showed typical blood test results for RA, i.e., an elevated erythrocyte sedimentation rate and C-reactive protein concentration, and positive for rheumatoid factor and anti-cyclic citrullinated peptide antibodies. RA was clear based on a total score of 10 when applying the classification criteria developed by the American College of Rheumatology/European League Against Rheumatism (2010). In an autoimmune target test, speckled and skeleton patterns were observed. In an ANCA test, p-ANCA was observed (titer, 1:2,560), and tests for anti-proteinase 3 (PR3) and anti-MPO antibodies were negative. After admission, multiple nodules were detected on a chest X-ray and a computed tomography scan. We suspected that she had rheumatic nodules or vasculitis and performed an open lung biopsy. We detected necrotic granulomatous vasculitis, classified as WG, thus leading to WG diagnosis. In conclusion, WG was diagnosed in an RA patient who was negative for c-ANCA (negative PR3) and positive for p-ANCA (negative anti-MPO), and this peculiar finding is likely to improve diagnosis in cases of RA with atypical WG.
Antibodies
;
Antibodies, Antineutrophil Cytoplasmic
;
Arthralgia
;
Arthritis, Rheumatoid*
;
Biopsy
;
Blood Sedimentation
;
C-Reactive Protein
;
Classification
;
Cytoplasm
;
Diagnosis
;
Female
;
Hematologic Tests
;
Humans
;
Korea
;
Lung
;
Rheumatic Diseases
;
Rheumatic Nodule
;
Rheumatoid Factor
;
Skeleton
;
Thorax
;
Vasculitis
;
Wegener Granulomatosis*
6.The diagnosis and treatment of the interstitial lung disease in infants.
Chinese Journal of Pediatrics 2014;52(4):257-259
Bronchopulmonary Dysplasia
;
diagnostic imaging
;
pathology
;
therapy
;
Female
;
Glycogen Storage Disease
;
diagnosis
;
pathology
;
therapy
;
Humans
;
Infant
;
Infant, Newborn
;
Lung
;
diagnostic imaging
;
growth & development
;
pathology
;
Lung Diseases, Interstitial
;
classification
;
diagnosis
;
pathology
;
therapy
;
Male
;
Neurosecretory Systems
;
pathology
;
Pediatrics
;
Tomography, X-Ray Computed
8.Chronic Pulmonary Disease Due to Mycobacterium monacense Infection: The First Case from Iran.
Hasan SHOJAEI ; Abodolrazagh HASHEMI ; Parvin HEIDARIEH ; Nafiseh HOSSEINI ; Abass DAEI NASER
Annals of Laboratory Medicine 2012;32(1):87-90
We herein report a case in which the recently characterized species Mycobacterium monacense was isolated from the sputum of an Iranian patient. This case represents the first isolation of M. monacense from Iran. The isolate was identified by conventional and molecular techniques. Our findings show that M. monacense infection is not restricted to developed countries.
Bacterial Proteins/genetics
;
Chaperonin 60/genetics
;
Chronic Disease
;
Female
;
Humans
;
Iran
;
Lung Diseases/diagnosis/*microbiology
;
Middle Aged
;
Mycobacterium/classification/*genetics/isolation & purification
;
Mycobacterium Infections/*microbiology/pathology
;
Polymerase Chain Reaction
;
RNA, Ribosomal, 16S/genetics
;
Sputum/microbiology
9.Multiple dimensions of cardiopulmonary dyspnea.
Jiang-Na HAN ; Chang-Ming XIONG ; Wei YAO ; Qiu-Hong FANG ; Yuan-Jue ZHU ; Xian-Sheng CHENG ;
Chinese Medical Journal 2011;124(20):3220-3226
BACKGROUNDThe current theory of dyspnea perception presumes a multidimensional conception of dyspnea. However, its validity in patients with cardiopulmonary dyspnea has not been investigated.
METHODSA respiratory symptom checklist incorporating spontaneously reported descriptors of sensory experiences of breathing discomfort, affective aspects, and behavioral items was administered to 396 patients with asthma, chronic obstructive pulmonary disease (COPD), diffuse parenchymal lung disease, pulmonary vascular disease, chronic heart failure, and medically unexplained dyspnea. Symptom factors measuring different qualitative components of dyspnea were derived by a principal component analysis. The separation of patient groups was achieved by a variance analysis on symptom factors.
RESULTSSeven factors appeared to measure three dimensions of dyspnea: sensory (difficulty breathing and phase of respiration, depth and frequency of breathing, urge to breathe, wheeze), affective (chest tightness, anxiety), and behavioral (refraining from physical activity) dimensions. Difficulty breathing and phase of respiration occurred more often in COPD, followed by asthma (R(2) = 0.12). Urge to breathe was unique for patients with medically unexplained dyspnea (R(2) = 0.12). Wheeze occurred most frequently in asthma, followed by COPD and heart failure (R(2) = 0.17). Chest tightness was specifically linked to medically unexplained dyspnea and asthma (R(2) = 0.04). Anxiety characterized medically unexplained dyspnea (R(2) = 0.08). Refraining from physical activity appeared more often in heart failure, pulmonary vascular disease, and COPD (R(2) = 0.15).
CONCLUSIONSThree dimensions with seven qualitative components of dyspnea appeared in cardiopulmonary disease and the components under each dimension allowed separation of different patient groups. These findings may serve as a validation on the multiple dimensions of cardiopulmonary dyspnea.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Asthma ; physiopathology ; Dyspnea ; classification ; diagnosis ; etiology ; Female ; Heart Failure ; physiopathology ; Humans ; Lung Diseases ; physiopathology ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive ; physiopathology ; Young Adult
10.Guideline of the Korean Academy of Medical Sciences for Assessing Respiratory Impairment.
Ho Joong KIM ; Kye Young LEE ; Joung Taek KIM ; Soo Taek UH
Journal of Korean Medical Science 2009;24(Suppl 2):S267-S270
The presently used impairment rating guidelines in Korea do not accurately reflect the injury in various lung diseases. Therefore, they need to be made more objective and quantitative with new measurements, using indicators to more precisely represent impairment in the major respiratory diseases. We develop a respiratory impairment rating guideline to ensure that the same grade or impairment rating would be obtained regardless of surgeons who determinate it. Specialists in respiratory medicine and thoracic surgeons determined the impairment grades. Moreover, the impairment should be irreversible for more than 6 months. The impairment rating depends on the level of forced vital capacity, forced expiratory volume 1 second, diffusion capacity of carbon monoxide, arterial oxygen pressure, and arterial carbon dioxide pressure. The degree of whole body impairment is defined by each grade: first 81-95%, second 66-80%, third 51-65%, fourth 36-50%, and fifth 21-35%. In conclusion, we develop a respiratory impairment rating guideline for Koreans. Any qualified specialist can easily use it and judge objective scoring.
*Disability Evaluation
;
Humans
;
Korea
;
Lung Diseases/classification/diagnosis
;
Program Development
;
Pulmonary Ventilation/physiology
;
Respiratory Insufficiency/classification/*diagnosis
;
Severity of Illness Index

Result Analysis
Print
Save
E-mail